"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Akash Maniam: The ADC Revolution Continues - Appreciating Structural and Toxicity Differences
Timothée Olivier: NATALEE trial - 3 years of adjuvant ribociclib in early breast cancer
Myeloma Paper of the Day, July 16th, Suggested by Robert Orlowski
ASCO CEO Clifford Hudis joined leaders at American Cancer and City of Hope to discuss the importance of partnerships in the future of cancer care - ASCO
2024 IASLC Distinguished Service Awards Recipients
Udhayvir Grewal: Impressive data for PDAC outcomes by metastatic site
